MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Effects of Vibrotactile Feedback and Lee Silverman Voice Treatment on Vocal Intensity in Individuals with Parkinson’s Disease: A Preliminary Study

R. Konnai, M. Van Harn, A. Silbergleit (West Bloomfield, MI, USA)
Efficacy and safety of CX-8998 in T-CALM, a randomized, double-blind, placebo-controlled, phase 2a trial in participants with essential tremor: subgroup analysis by baseline tremor severity

H. Jinnah, S. Papapetropoulos, M. Lee, S. Versavel, E. Newbold, R. Pahwa, K. Lyons, R. Elble, W. Ondo, T. Zesiewicz, P. Hedera, A. Handforth, J. Elder, M. Versavel (Atlanta, GA, USA)
Efficacy and Safety of High Doses of Safinamide in Advanced Parkinson’s Disease Patients in a Real-World Experience

F. Rodríguez Jorge, A. Beltrán Corbellini, P. Parra Díaz, J.L Chico García, J. Pagonabarraga Mora, B. Baena Álvarez, I. Parées Moreno, J.L López-Sendón, P. Pérez Torre, J.C Martínez Castrillo, A. Alonso Cánovas (Madrid, Spain)
Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects

Y. Masakado, A. Dekundy, A. Hanschmann, R. Kaji (Kanagawa, Japan)
Efficacy and safety of istradefylline in Parkinson’s disease patients with postural abnormality: Results from a multicenter, open-label study in Japan

M. Takahashi, T. Shimokawa, J. Koh, T. Takeshima, H. Yamashita, Y. Kajimoto, A. Mori, H. Ito (Osaka, Japan)
Efficacy and safety of levodopa-carbidopa intestinal gel (LCIG) for advanced Parkinson’s disease: a Turkish single-centre experience

Y. Sucullu Karadag (Ankara, Turkey)
Efficacy and Safety of Opicapone in Parkinson’s Disease Patients According to Duration of Motor Fluctuations: Post-Hoc Analysis of BIPARK-I and II

G. Ebersbach, O. Rascol, J. Ferreira, R. Costa, J.F Rocha, D. Magalhães, P. Soares-da-Silva (Beelitz, Germany)
Efficacy and safety/tolerability of opicapone in catechol-O-methyltransferase inhibitor-naïve Parkinson’s disease patients recently diagnosed with motor fluctuations

A. Lees, J. Ferreira, W. Poewe, H. Gama, D. Magalhães, J.F Rocha, P. Soares-da-Silva (London, United Kingdom)
Efficacy and security starting safinamide treatment with 100 mg/day in Parkinson’s disease

N. Foncea (Galdakao, Spain)
Efficacy and tolerability of opicapone in Parkinson´s disease in usual clinical practice

V. Gomez-Mayordomo, F. Alonso-Frech, E. Lopez-Valdes, R. Garcia-Ramos, M. Catalan-Alonso (Madrid, Spain)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z